No. Compounded medications are not FDA-approved. Compounded NAD+, sermorelin, glutathione and MIC + B12 are prepared for individual patients by VialsRx, a US-licensed 503A compounding pharmacy, on a licensed provider’s prescription, and none is an FDA-approved product. FDA's Pharmacy Compounding Advisory Committee voted in May 2017 not to add NAD (nicotinamide adenine dinucleotide, the ingredient in compounded NAD+) to FDA's list of bulk ingredients pharmacies can use in 503A compounding, and in a 2019 proposed rule FDA proposed not to add it. The committee's votes are advisory, and the rule has not been finalized. Glutathione is in Category 1 of FDA's list of bulk drug substances nominated for 503A compounding, the substances FDA is still evaluating (list updated May 14, 2026). In June 2022, FDA's position before its Pharmacy Compounding Advisory Committee was that glutathione should not be added to FDA's list of bulk ingredients pharmacies can use in 503A compounding; the committee voted to recommend adding it. The committee's votes are advisory, and FDA has not issued a rule.

No. Each medication has its own intake and its own membership, separate from any GLP-1 plan. A GLP-1 plan through Cora does not include or require any of them.

Not necessarily. A licensed provider reviews your intake and decides whether the medication is appropriate for you, and may decline.

Each medication is a membership billed monthly, every 3 months, every 6 months or every 12 months, at the price listed for that term. Each price covers your provider visit and check-ins, the medication if it is prescribed, and shipping, with no other fees. Every term renews automatically until you cancel.

Message the care team in your patient portal. Cancellation and refund terms are in our Terms of Service and Refund Policy.

VialsRx, a US-licensed 503A compounding pharmacy, prepares and ships it on your provider’s prescription. Cora Health does not prescribe, compound or dispense medication.